Osimertinib - Globe Thesis

Keyword [Osimertinib] Result: 1 - 20 \| Page: 1 of 3
1.	The Research On The Activity Of Osimertinib And Dexamethasone In EGFR Inhibitor-resistant Non-small Cell Lung Cancer
2.	Synergistic Efficacy Of Metformin In Combination With Osimertinib In PC9/GR Cells.
3.	In Vitro Study Of Aspirin Combined With Osimertinib In Inhibiting Of Non-small Cell Lung Cancer
4.	Drug Concentrations And Pharmacodynamic Analysis Of Osimertinib And Recombinant Human-murine Chimeric Anti-CD20 Monoclonal Antibody In Cancer Patients
5.	Study On The Efficacy And Mechanism Of Pantoprazole Enhances Osimertinib Activity By Inhibiting Autophagy In Human Lung Cancer Cells And Patient Derived Xenograft Models Of Lung Cancer
6.	Establishment Of Third Generation EGFR-TKI Osimertinib Acquired Resistant NSCLC Cell Line And Preliminary Study On Resistance Mechanism
7.	Characteristics And Survival In Non-small Cell Lung Cancer Patients Harbored Primary And Acquired EGFR T790M Mutation
8.	Study On The Antitumor Activity Of Novel Nitroheterocyclic Compounds Based On LSD1 And LSD1 Neddylation
9.	Clinical Efficacy Of Osimertinib In Advanced Non-small Cell Lung Cancer
10.	A Preclinical Study Of Osimertinib(AZD9291) Combined With Radiation For EGFR T790M Mutant Nonsmall Cell Lung Cancer
11.	Synergistic Inhibitory Effect Of Osimertinib In Combination With Quercetin On Proliferation Of Non-small Cell Lung Cancer H1975 Cells
12.	Screening And Identification Of Osimertinib Resistance Gene In Non-small Cell Lung Cancer By CRISPR/Cas9 Library
13.	The Association Between BIM Deletion Polymorphism And Therapeutic Efficacy In Advanced EGFR T790M NSCLC With Osimertinib
14.	Observation On The Therapeutic Effect Of Osimertinib In The Treatment Of Advanced Non-small Cell Lung Cancer
15.	The Role And Mechanism Of 2-DG In Reversing Osimertinib-acquired Resistance Of NSCLC Cell Line
16.	Establ Ishment Of An Osimertinib-resi Stant Cell Line Of Human Non-small Cell Lung Cancer And The Subsequent Sensitivity Of Themotherapeutic Drugs
17.	Biological Electric Fields Guide The Directional Migration Of Lung Cancer Cell And Suppress Osimertinib-induced Cytotoxicity Through AKT Activation
18.	Retrospective Study Of Advanced NSCLC Chinese Patients With EGFR Mutation-positive Treated With Osimertinib
19.	Correlation Between Clinical Features Of Patients With Advanced NSCLC After The First Generation EGFR-TKIS Resistance And T790M Mutation,the Efficacy Of Osimertinib
20.	Process Research Of Osimertinib And Design,Synthesis And Preliminary Activity Study Of EGFR And HDACs Dual-Target Inhibitors
<<First <Prev Next> Last>> Jump to